{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T18:17:20Z","timestamp":1788891440972,"version":"build-2803163510"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.intimp.2024.112422","type":"journal-article","created":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T10:18:21Z","timestamp":1718446701000},"page":"112422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Berberine, a natural alkaloid: Advances in its pharmacological effects and mechanisms in the treatment of autoimmune diseases"],"prefix":"10.1016","volume":"137","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5390-2672","authenticated-orcid":false,"given":"Zhifang","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3795-4399","authenticated-orcid":false,"given":"Xiaoyi","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.112422_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110984","article-title":"Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence","volume":"133","author":"Xu","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.intimp.2024.112422_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27123705","article-title":"Expatiating the Pharmacological and Nanotechnological Aspects of the Alkaloidal Drug Berberine: Current and Future Trends","volume":"27","author":"Behl","year":"2022","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.intimp.2024.112422_b0015","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1172\/JCI97965","article-title":"Long noncoding RNA LERFS negatively regulates rheumatoid synovial aggression and proliferation","volume":"128","author":"Zou","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.intimp.2024.112422_b0020","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/cmi.2016.60","article-title":"uPAR promotes tumor-like biologic behaviors of fibroblast-like synoviocytes through PI3K\/Akt signaling pathway in patients with rheumatoid arthritis","volume":"15","author":"Liu","year":"2018","journal-title":"Cell. Mol. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2024.112422_b0025","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2105\/AJPH.90.9.1463","article-title":"Autoimmune diseases: a leading cause of death among young and middle-aged women in the United States","volume":"90","author":"Walsh","year":"2000","journal-title":"Am. J. Public Health"},{"issue":"6","key":"10.1016\/j.intimp.2024.112422_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102532","article-title":"Comprehensive meta-analysis reveals an association of the HLA-DRB1*1602 allele with autoimmune diseases mediated predominantly by autoantibodies","volume":"19","author":"Chen","year":"2020","journal-title":"Autoimmun. Rev."},{"issue":"5","key":"10.1016\/j.intimp.2024.112422_b0035","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.autrev.2019.03.013","article-title":"Influence of HLA-DRB1 susceptibility alleles on the autoantibodies spectrum of systemic lupus erythematosus in European part of Russia","volume":"18","author":"Tkachenko","year":"2019","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.intimp.2024.112422_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102743","article-title":"An updated advance of autoantibodies in autoimmune diseases","volume":"20","author":"Xiao","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2024.112422_b0045","article-title":"Piperine suppresses inflammatory fibroblast-like synoviocytes derived from rheumatoid arthritis patients Via NF-\u03baB inhibition","volume":"391\u2013392","author":"Baito","year":"2023","journal-title":"Cell. Immunol."},{"issue":"15","key":"10.1016\/j.intimp.2024.112422_b0050","doi-asserted-by":"crossref","first-page":"7247","DOI":"10.1039\/D3FO00122A","article-title":"Ketogenic diet attenuates neuroinflammation and induces conversion of M1 microglia to M2 in an EAE model of multiple sclerosis by regulating the NF-\u03baB\/NLRP3 pathway and inhibiting HDAC3 and P2X7R activation","volume":"14","author":"Sun","year":"2023","journal-title":"Food Funct."},{"issue":"12","key":"10.1016\/j.intimp.2024.112422_b0055","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/s41419-019-2157-1","article-title":"NEK7 interacts with NLRP3 to modulate the pyroptosis in inflammatory bowel disease via NF-\u03baB signaling","volume":"10","author":"Chen","year":"2019","journal-title":"Cell Death Dis."},{"issue":"42","key":"10.1016\/j.intimp.2024.112422_b0060","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1093\/eurheartj\/ehab447","article-title":"The JAK-STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms","volume":"42","author":"Baldini","year":"2021","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.intimp.2024.112422_b0065","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2174\/1874467214666210301121432","article-title":"Connection between JAK\/STAT and PPAR\u03b3 signaling during the progression of multiple sclerosis: insights into the modulation of T-Cells and immune responses in the brain","volume":"14","author":"Kumar","year":"2021","journal-title":"Curr. Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112422_b0070","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s40265-020-01261-8","article-title":"JAK inhibitors for treatment of psoriasis: focus on selective TYK2 inhibitors","volume":"80","author":"Nogueira","year":"2020","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.intimp.2024.112422_b0075","doi-asserted-by":"crossref","first-page":"13524","DOI":"10.1038\/s41598-023-39805-z","article-title":"JT002, a small molecule inhibitor of the NLRP3 inflammasome for the treatment of autoinflammatory disorders","volume":"13","author":"Ambrus-Aikelin","year":"2023","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.intimp.2024.112422_b0080","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s10067-024-06871-1","article-title":"Natural compound library screening to identify berberine as a treatment for rheumatoid arthritis","volume":"43","author":"Zhang","year":"2024","journal-title":"Clin. Rheumatol."},{"issue":"6","key":"10.1016\/j.intimp.2024.112422_b0085","first-page":"720","article-title":"Berberine attenuates NLRP3 inflammasome activation in macrophages to reduce the secretion of interleukin-1\u03b2","volume":"47","author":"Jiang","year":"2017","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.intimp.2024.112422_b0090","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.653887","article-title":"Efficacy and safety of berberine alone for several metabolic disorders: a systematic review and meta-analysis of randomized clinical trials","volume":"12","author":"Ye","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112422_b0095","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.631100","article-title":"A new therapeutic candidate for cardiovascular diseases: berberine","volume":"12","author":"Cai","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"10055","key":"10.1016\/j.intimp.2024.112422_b0100","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.intimp.2024.112422_b0105","doi-asserted-by":"crossref","first-page":"12234","DOI":"10.1111\/jcmm.15803","article-title":"Immunomodulatory effects of berberine on the inflamed joint reveal new therapeutic targets for rheumatoid arthritis management","volume":"24","author":"Shen","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"6","key":"10.1016\/j.intimp.2024.112422_b0110","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/rheumatology\/kel065","article-title":"Synovial fibroblasts: key players in rheumatoid arthritis","volume":"45","author":"Huber","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.intimp.2024.112422_b0115","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.coph.2004.04.003","article-title":"Interleukin-15: a new cytokine target for the treatment of inflammatory diseases","volume":"4","author":"McInnes","year":"2004","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112422_b0120","doi-asserted-by":"crossref","first-page":"2580207","DOI":"10.1155\/2019\/2580207","article-title":"Berberine Modulates LPA Function to Inhibit the Proliferation and Inflammation of FLS-RA via p38\/ERK MAPK Pathway Mediated by LPA(1)","volume":"2019","author":"Wang","year":"2019","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"2","key":"10.1016\/j.intimp.2024.112422_b0125","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1302\/2046-3758.122.BJR-2022-0269.R1","article-title":"Berberine inhibits RA-FLS cell proliferation and adhesion by regulating RAS\/MAPK\/FOXO\/HIF-1 signal pathway in the treatment of rheumatoid arthritis","volume":"12","author":"Li","year":"2023","journal-title":"Bone Joint Res"},{"issue":"7\u20138","key":"10.1016\/j.intimp.2024.112422_b0130","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s10495-019-01548-6","article-title":"Berberine mitigates IL-21\/IL-21R mediated autophagic influx in fibroblast-like synoviocytes and regulates Th17\/Treg imbalance in rheumatoid arthritis","volume":"24","author":"Dinesh","year":"2019","journal-title":"Apoptosis"},{"key":"10.1016\/j.intimp.2024.112422_b0135","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cyto.2018.03.005","article-title":"Berberine inhibits IL-21\/IL-21R mediated inflammatory proliferation of fibroblast-like synoviocytes through the attenuation of PI3K\/Akt signaling pathway and ameliorates IL-21 mediated osteoclastogenesis","volume":"106","author":"Dinesh","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2024.112422_b0140","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejpb.2020.02.007","article-title":"Berberine encapsulated PEG-coated liposomes attenuate Wnt1\/\u03b2-catenin signaling in rheumatoid arthritis via miR-23a activation","volume":"149","author":"Sujitha","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"7","key":"10.1016\/j.intimp.2024.112422_b0145","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1258\/ebm.2011.010366","article-title":"Effects of berberine on human rheumatoid arthritis fibroblast-like synoviocytes","volume":"236","author":"Wang","year":"2011","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"4","key":"10.1016\/j.intimp.2024.112422_b0150","first-page":"552","article-title":"Berberine inhibits autophagy and promotes apoptosis of fibroblast-like synovial cells from rheumatoid arthritis patients through the ROS\/mTOR signaling pathway","volume":"43","author":"Zong","year":"2023","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"1","key":"10.1016\/j.intimp.2024.112422_b0155","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.intimp.2014.08.024","article-title":"The role of prostaglandin E2 receptor signaling of dendritic cells in rheumatoid arthritis","volume":"23","author":"Jia","year":"2014","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112422_b0160","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/BOR.0000000000000251","article-title":"The thymus and rheumatology: should we care?","volume":"28","author":"Cosway","year":"2016","journal-title":"Curr. Opin. Rheumatol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112422_b0165","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.immuni.2008.03.006","article-title":"The STATs on dendritic cell development","volume":"28","author":"Onai","year":"2008","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.intimp.2024.112422_b0170","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/art.30202","article-title":"Berberine induces dendritic cell apoptosis and has therapeutic potential for rheumatoid arthritis","volume":"63","author":"Hu","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.intimp.2024.112422_b0175","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1136\/annrheumdis-2014-207137","article-title":"RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation","volume":"75","author":"Danks","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2024.112422_b0180","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3892\/mmr.2014.2182","article-title":"RNA-seq analysis of synovial fibroblasts in human rheumatoid arthritis","volume":"10","author":"Wang","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.intimp.2024.112422_b0185","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.bone.2015.05.024","article-title":"Inflammatory signaling induced bone loss","volume":"80","author":"Goldring","year":"2015","journal-title":"Bone"},{"issue":"23","key":"10.1016\/j.intimp.2024.112422_b0190","doi-asserted-by":"crossref","first-page":"13573","DOI":"10.1111\/jcmm.16049","article-title":"Anti-inflammatory and immune-modulatory impacts of berberine on activation of autoreactive T cells in autoimmune inflammation","volume":"24","author":"Ehteshamfar","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"2","key":"10.1016\/j.intimp.2024.112422_b0195","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1055\/s-0038-1649502","article-title":"Multiple Sclerosis","volume":"38","author":"Yamout","year":"2018","journal-title":"Semin. Neurol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112422_b0200","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.intimp.2010.08.013","article-title":"Curcumin has bright prospects for the treatment of multiple sclerosis","volume":"11","author":"Xie","year":"2011","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112422_b0205","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.13819","article-title":"Multiple sclerosis - a review","volume":"26","author":"Dobson","year":"2019","journal-title":"Eur. J. Neurol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112422_b0210","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.bbrc.2017.06.142","article-title":"The effects of berberine on a murine model of multiple sclerosis and the SPHK1\/S1P signaling pathway","volume":"490","author":"Luo","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2024.112422_b0215","doi-asserted-by":"crossref","first-page":"e766","DOI":"10.1002\/iid3.766","article-title":"Berberine promotes immunological outcomes and decreases neuroinflammation in the experimental model of multiple sclerosis through the expansion of Treg and Th2 cells","volume":"11","author":"Tavaf","year":"2023","journal-title":"Immun Inflamm Dis"},{"issue":"5","key":"10.1016\/j.intimp.2024.112422_b0220","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrgastro.2016.208","article-title":"Current and emerging therapeutic targets for IBD","volume":"14","author":"Neurath","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"9","key":"10.1016\/j.intimp.2024.112422_b0225","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11894-021-00816-3","article-title":"Epidemiology of colorectal cancer in inflammatory bowel disease - the evolving landscape","volume":"23","author":"Linson","year":"2021","journal-title":"Curr. Gastroenterol. Rep."},{"issue":"Pt A","key":"10.1016\/j.intimp.2024.112422_b0230","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.phrs.2016.09.041","article-title":"Berberine and inflammatory bowel disease: A concise review","volume":"113","author":"Habtemariam","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.intimp.2024.112422_b0235","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2796.2008.01953.x","article-title":"NF-kappaB in inflammatory bowel disease","volume":"263","author":"Atreya","year":"2008","journal-title":"J. Intern. Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.112422_b0240","article-title":"Integrating immunologic signaling networks: The JAK\/STAT pathway in colitis and colitis-associated cancer","volume":"4","author":"Zundler","year":"2016","journal-title":"Vaccines (basel)"},{"issue":"1","key":"10.1016\/j.intimp.2024.112422_b0245","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S1359-6101(98)00022-7","article-title":"Insulin-like growth factor-1 (IGF-1) and growth hormone (GH) in immunity and inflammation","volume":"10","author":"Heemskerk","year":"1999","journal-title":"Cytokine Growth Factor Rev."},{"issue":"5","key":"10.1016\/j.intimp.2024.112422_b0250","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/00007890-199503150-00020","article-title":"Insulin-like growth factor-I improves mucosal structure and function in transplanted rat small intestine","volume":"59","author":"Zhang","year":"1995","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.intimp.2024.112422_b0255","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.bcp.2010.08.009","article-title":"AMPK agonist downregulates innate and adaptive immune responses in TNBS-induced murine acute and relapsing colitis","volume":"80","author":"Bai","year":"2010","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112422_b0260","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00011-016-1005-3","article-title":"Demethyleneberberine alleviates inflammatory bowel disease in mice through regulating NF-\u03baB signaling and T-helper cell homeostasis","volume":"66","author":"Chen","year":"2017","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.intimp.2024.112422_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105358","article-title":"Berberine improves colitis by triggering AhR activation by microbial tryptophan catabolites","volume":"164","author":"Jing","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2024.112422_b0270","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.intimp.2018.12.036","article-title":"Protective effects of berberine hydrochloride on DSS-induced ulcerative colitis in rats","volume":"68","author":"Zhu","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112422_b0275","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.apsb.2019.08.006","article-title":"Protective role of berberine on ulcerative colitis through modulating enteric glial cells-intestinal epithelial cells-immune cells interactions","volume":"10","author":"Li","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"4","key":"10.1016\/j.intimp.2024.112422_b0280","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.7150\/ijbs.65476","article-title":"Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt\/\u03b2-catenin pathway","volume":"18","author":"Dong","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2024.112422_b0285","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment","volume":"20","author":"Rendon","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.intimp.2024.112422_b0290","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184347","article-title":"Risk factors for the development of psoriasis","volume":"20","author":"Kamiya","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"10281","key":"10.1016\/j.intimp.2024.112422_b0295","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"issue":"10275","key":"10.1016\/j.intimp.2024.112422_b0300","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","article-title":"Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis","volume":"397","author":"Ghoreschi","year":"2021","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.intimp.2024.112422_b0305","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.112422_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124051","article-title":"Nanodiamond-based berberine aquasomes for enhancing penetration across epidermis to treat psoriasis","volume":"656","author":"Kulkarni","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.intimp.2024.112422_b0315","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41419-019-1510-8","article-title":"Berberine downregulates CDC6 and inhibits proliferation via targeting JAK-STAT3 signaling in keratinocytes","volume":"10","author":"Sun","year":"2019","journal-title":"Cell Death Dis."},{"issue":"21","key":"10.1016\/j.intimp.2024.112422_b0320","doi-asserted-by":"crossref","DOI":"10.3390\/polym13213833","article-title":"Development of natural polysaccharide-based nanoparticles of berberine to enhance oral bioavailability: formulation, optimization, ex vivo, and in vivo assessment","volume":"13","author":"Kohli","year":"2021","journal-title":"Polymers (basel)"},{"issue":"12","key":"10.1016\/j.intimp.2024.112422_b0325","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1166\/jbn.2020.30041755","article-title":"Mixed micelles with galactose ligands for the oral delivery of berberine to enhance its bioavailability and hypoglycemic effects","volume":"16","author":"Kang","year":"2020","journal-title":"J. Biomed. Nanotechnol."},{"issue":"Pt 2","key":"10.1016\/j.intimp.2024.112422_b0330","article-title":"Chitosan\/alginate nanogel potentiate berberine uptake and enhance oxidative stress mediated apoptotic cell death in HepG2 cells","volume":"257","author":"Singh","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112422_b0335","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1208\/s12249-022-02241-9","article-title":"In vitro and in vivo evaluations of berberine-loaded microparticles filled in-house 3D printed hollow capsular device for improved oral bioavailability","volume":"23","author":"Choudhury","year":"2022","journal-title":"AAPS PharmSciTech"},{"issue":"38","key":"10.1016\/j.intimp.2024.112422_b0340","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.2174\/0113816128263982231102062745","article-title":"Spray-dried solid lipid nanoparticles for enhancing berberine bioavailability via oral administration","volume":"29","author":"Nguyen","year":"2023","journal-title":"Curr. Pharm. Des."},{"issue":"11","key":"10.1016\/j.intimp.2024.112422_b0345","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1248\/bpb.b23-00444","article-title":"Comparison of berberine bioavailability between oral and rectal administrations in rats","volume":"46","author":"Mori","year":"2023","journal-title":"Biol. Pharm. Bull."},{"issue":"2","key":"10.1016\/j.intimp.2024.112422_b0350","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1208\/s12249-011-9632-z","article-title":"Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats","volume":"12","author":"Chen","year":"2011","journal-title":"AAPS PharmSciTech"},{"issue":"7","key":"10.1016\/j.intimp.2024.112422_b0355","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/jpp\/rgad028","article-title":"DSPE-PEG polymer enhanced berberine absorption specifically in the small intestine of rats through paracellular passway","volume":"75","author":"Gao","year":"2023","journal-title":"J. Pharm. Pharmacol."},{"issue":"7","key":"10.1016\/j.intimp.2024.112422_b0360","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.apsb.2020.09.013","article-title":"The influence of the gut microbiota on the bioavailability of oral drugs","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.intimp.2024.112422_b0365","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1158\/1940-6207.CAPR-19-0258","article-title":"A phase I trial of berberine in chinese with ulcerative colitis","volume":"13","author":"Xu","year":"2020","journal-title":"Cancer Prev. Res. (Phila.)"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924009433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924009433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T15:34:49Z","timestamp":1720280089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924009433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":73,"alternative-id":["S1567576924009433"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112422","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Berberine, a natural alkaloid: Advances in its pharmacological effects and mechanisms in the treatment of autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112422","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112422"}}